CapsoVision, Inc. Common Stock (CV) - Total Liabilities

Latest as of December 2025: $4.90 Million USD

Based on the latest financial reports, CapsoVision, Inc. Common Stock (CV) has total liabilities worth $4.90 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore CV year-over-year net asset growth to track the company's year-over-year net asset growth rate.

CapsoVision, Inc. Common Stock - Total Liabilities Trend (2023–2025)

This chart illustrates how CapsoVision, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data.

CapsoVision, Inc. Common Stock Competitors by Total Liabilities

The table below lists competitors of CapsoVision, Inc. Common Stock ranked by their total liabilities.

Company Country Total Liabilities
Tien Phong Securities Corp
VN:ORS
Vietnam ₫6.95 Trillion
Hoasen Group
VN:HSG
Vietnam ₫9.68 Trillion
Beijing Infosec Technologies Co. Ltd. A
SHG:688201
China CN¥179.35 Million
Interarch Building Products Limited
NSE:INTERARCH
India Rs4.20 Billion
Santana Minerals Ltd
AU:SMI
Australia AU$5.18 Million
Guangdong Anjubao Digital Tech
SHE:300155
China CN¥138.36 Million
Asia Aviation Public Company Limited
F:55AA
Germany €62.78 Billion
Wonderla Holidays Limited
NSE:WONDERLA
India Rs1.36 Billion

Liability Composition Analysis (2023–2025)

This chart breaks down CapsoVision, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CapsoVision, Inc. Common Stock (CV) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.77 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.37 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.27 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CapsoVision, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CapsoVision, Inc. Common Stock (2023–2025)

The table below shows the annual total liabilities of CapsoVision, Inc. Common Stock from 2023 to 2025.

Year Total Liabilities Change
2025-12-31 $4.90 Million -96.65%
2024-12-31 $146.31 Million +11.37%
2023-12-31 $131.37 Million --

About CapsoVision, Inc. Common Stock

NASDAQ:CV USA Medical Devices
Market Cap
$328.01 Million
Market Cap Rank
#14231 Global
#3384 in USA
Share Price
$6.58
Change (1 day)
-1.79%
52-Week Range
$3.56 - $14.42
All Time High
$14.42
About

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement … Read more